Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock
Wednesday, 16 July 2025 ()
Switzerland-based cancer treatment developer BeOne Medicines (ONC) is having a good week. Its stock has climbed nearly 11% so far over the last three sessions. Several factors may be boosting the biotech stock. The IBD 50 Growth Stocks To Watch pick for Wednesday may be rising in sympathy with Dow…
|
||||
|
|
||||
You Might Like |
||||
